Entry |
|
Name |
Nandrolone (INN); decadura (TN) |
Formula |
C18H26O2
|
Exact mass |
274.1933
|
Mol weight |
274.40
|
Structure |

|
Simcomp |
|
Class |
Hormonal agent
DG01590 Androgen receptor agonist
DG01605 Anabolic steroid
|
Remark |
|
Efficacy |
Anabolic, Androgen receptor agonist |
Comment |
Estren derivative
|
Target |
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A14 ANABOLIC AGENTS FOR SYSTEMIC USE
A14A ANABOLIC STEROIDS
A14AB Estren derivatives
A14AB01 Nandrolone
D08250 Nandrolone (INN)
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01X OTHER OPHTHALMOLOGICALS
S01XA Other ophthalmologicals
S01XA11 Nandrolone
D08250 Nandrolone (INN)
Drug groups [BR:br08330]
Hormonal agent
DG01590 Androgen receptor agonist
DG01605 Anabolic steroid
DG00142 Nandrolone
D08250 Nandrolone
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Estrogen like receptors
3-Ketosteroid receptor
NR3C4 (AR)
D08250 Nandrolone (INN)
Drug groups [BR:br08330]
Hormonal agent
DG01590 Androgen receptor agonist
DG01605 Anabolic steroid
DG00142 Nandrolone
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 20
1 C1y C 21.0566 -16.7421
2 C1y C 19.8006 -17.3701
3 C1z C 21.0569 -15.3465
4 C1x C 23.2896 -16.7421
5 C1y C 18.6143 -16.6723
6 C1x C 19.8006 -18.6959
7 C1x C 19.8006 -14.7185
8 C1y C 22.1034 -14.7185
9 C1a C 20.9871 -13.9506
10 C1x C 23.2896 -15.4163
11 C1y C 17.4281 -17.3701
12 C1x C 18.6143 -15.3465
13 C1x C 18.6143 -19.3938
14 O1a O 22.1029 -12.9737
15 C2y C 17.4281 -18.6959
16 C1x C 16.3116 -16.6723
17 C2x C 16.3116 -19.3938
18 C1x C 15.1253 -17.3701
19 C5x C 15.1253 -18.6959
20 O5x O 13.9390 -19.3938
BOND 23
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 3 8 1
8 3 9 1 #Up
9 4 10 1
10 5 11 1
11 5 12 1
12 6 13 1
13 8 14 1 #Up
14 11 15 1
15 11 16 1
16 15 17 2
17 16 18 1
18 17 19 1
19 19 20 2
20 7 12 1
21 8 10 1
22 13 15 1
23 18 19 1
|